Navigation Links
Pharmatek Announces Official Opening of New Highly-Potent & Cytotoxic Development and Manufacturing Facility
Date:9/17/2008

New Facility Enables Pharmatek to Serve Growing Highly-Potent and Cytotoxic

Compound Market

SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- Pharmatek -- a pharmaceutical chemistry development organization supporting the pharmaceutical industry -- today announced the opening of its highly-potent and cytotoxic facility located in San Diego.

The 18,000 sq. ft. facility includes newly constructed analytical and formulation development laboratories and cGMP manufacturing suites dedicated to the development of highly-potent and cytotoxic drug product for early phase clinical trials.

"Highly-potent and cytotoxic compounds are among the most sensitive drugs to handle and produce," said Kevin Rosenthal, director of manufacturing of Pharmatek. "Our primary goal when designing the facility was to optimize product quality while ensuring operator safety to guarantee our clients' drug candidates move smoothly from discovery to clinical trials."

The facility holds a State of California Food and Drug Branch (FDB) Drug Manufacturers License and is currently working on a number of highly-potent development projects. The FDB license authorizes Pharmatek to manufacture and ship clinical material from its state-of-the-art highly-potent and cytotoxic manufacturing and development site.

"The highly-potent facility is a significant addition to our service offering," said Timothy Scott, president of Pharmatek. "We are always looking for ways to better meet our client's drug development outsourcing needs, and the highly-potent and cytotoxic facility strengthens our ability to provide a broader level of services to our clients."

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to t
'/>"/>

SOURCE Pharmatek
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... 21, 2012   Cord Blood America, Inc . ... ), the umbilical cord blood stem cell preservation ... of stem cells to families nationwide and internationally, today ... increased by 6.7%  to $1.55 million compared to $1.45 ... a gross profit of $1.12 million in the first ...
(Date:5/21/2012)... CITY, Panama, May 21, 2012 ... 16 May 2012 to discuss the potential use of ... a tool to combat Dengue Fever in Panama. ... Tropical Research Institute (STRI), The Gorgas Memorial Institute for ... together national and regional experts from these institutes as ...
(Date:5/18/2012)... HACKENSACK, N.J., May 18, 2012 Champions ... has received U.S. Clinical Laboratory Improvement Amendment (CLIA) ... Mental Hygiene Office of Health Care Quality required ... The Company,s President, Ronnie Morris, ... milestone for our Company. This approval validates the ...
(Date:5/17/2012)... 17, 2012 The " ... Study " analyzes and studies the U.S. market for ... anesthesia drugs in U.S., potential buyers, export & import system for ... Browse market data tables and in-depth TOC of ... 2015) -   U.S. Market Entry ...
Breaking Biology Technology:Cord Blood America Announces First Quarter Financial Results 2Cord Blood America Announces First Quarter Financial Results 3Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities 2Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities 3Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 2Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 3
... Inc. (Nasdaq: AMLN ) confirmed today that it ... and affiliated funds announcing their intent to nominate a slate ... 2009 annual meeting. The notice from the Icahn group ... approval requesting that the Company reincorporate in the state of ...
... NEOG ) announced the appointment of ... this newly created position, Dr. Rice will have,responsibility ... , "Dr. Rice brings ... said James Herbert, Neogen,s chief executive officer. "She ...
... Mass., Jan. 30 Jeff Olson, Manager of Nucleic ... Enrichment of Genomic Loci for Targeted Sequencing Applications ... RainStorm micro-droplet technology on the new RDT 1000 instrument, ... (AGBT) conference on Friday, February 6th, in Marco Island, ...
Other Biology Technology:Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices 2Neogen Names New Senior Science Officer; Added to S&P Index 2'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop 2'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop 3
(Date:5/21/2012)... 2012 Researchers from Seattle Biomedical Research Institute (Seattle ... Edinburgh have uncovered new knowledge related to host-parasite interaction ... to bind to cells in the brain and cause ... disease. Three related papers will be published in the ... the National Academy of Sciences ), a premier scientific ...
(Date:5/21/2012)... 21, 2012  Chiltern International Limited (Chiltern), a ... has been recognized with a CRO Leadership Award ... and Regulatory. The awards are given by Life ... of Nice Insight. Glenn ... to be recognized as a CRO leader in ...
(Date:5/21/2012)... combination of cues in their hunting sequence - capture, handling ... and consume and which ones they are better off leaving ... listen to their prey, then they assess its size, and ... and her team from the Smithsonian Tropical Research Institute in ... The Science of Nature . , To survive, predators must ...
Breaking Biology News(10 mins):New discoveries about severe malaria 2Chiltern Wins CRO Leadership Award From Life Science Leader 2What sounds good doesn't always taste good 2Depression associated with sustained brain signals 12686 1Depression associated with sustained brain signals 12686 2Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 1Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 2Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 3Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast 70037 4Childhood Cancer Survivors At Higher Odds of Early Death 70034 1Childhood Cancer Survivors At Higher Odds of Early Death 70034 2
... Women who have had two or more induced abortions have ... not currently understood to what degree physical activity during pregnancy ... in two new studies from the Norwegian Institute of Public ... Child Cohort Study (MoBa). , The new results from ...
... by North Carolina State University has made a breakthrough that ... other revolutionary medical implants. The researchers have found that the ... create new devices that can be implanted into the human ... hemo-dialysis membranes that can scrub impurities from the blood. , ...
... Lecture was established in 1990 to emphasize to the ... molecular sciences play in our lives. Ullyot Lectures are ... lecturers are distinguished in their fields, nationally recognized, and ... year,s lecture will be given by Bernard Bigot, high ...
Other Biology News:Previous abortions and exercise: Do they affect pregnancy? 2Previous abortions and exercise: Do they affect pregnancy? 3NC State finds new nanomaterial could be breakthrough for implantable medical devices 2